Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The T-PLL Channel

Explore the latest updates and expert interviews

Welcome to The T-cell prolymphocytic leukemia (T-PLL) Channel

VJHemOnc covers exciting and topical research directly from the experts at major international congresses so that you can stay informed.

Catch up on updates in T-PLL by watching our video interviews with leading experts.

Challenges with diagnosing mature T-cell leukemias 2:21
Challenges with diagnosing mature T-cell leukemias
Dima El-Sharkawi • 24 Apr 2023
Pathobiology & treatment of T-PLL 3:55
Pathobiology & treatment of T-PLL
Marco Herling • 12 Jun 2022
Itacitinib plus alemtuzumab for patients with T-PLL 2:58
Itacitinib plus alemtuzumab for patients with T-PLL
Tapan Kadia • 10 Jun 2022
PET scans in NHL 1:55
PET scans in NHL
Sally Barrington • 9 Jun 2021
Ruxolitinib plus venetoclax for T-PLL: rationale and findings 1:26
Ruxolitinib plus venetoclax for T-PLL: rationale and findings
Charles Herbaux • 25 May 2021
The biology of T-ALL 2:42
The biology of T-ALL
Scott Armstrong • 10 May 2021
Should AMTL be defined as a distinct diagnostic entity? 1:40
Should AMTL be defined as a distinct diagnostic entity?
Jonathan Bond • 18 Jun 2020
Acute leukemias at the T-lymphoid/myeloid interface 12:51
Acute leukemias at the T-lymphoid/myeloid interface
Jonathan Bond • 18 Jun 2020
Off-the-shelf CAR-T for T-cell malignancies: UCART3 1:28
Off-the-shelf CAR-T for T-cell malignancies: UCART3
John DiPersio
The diagnosis of early T-cell precursor (ETP) ALL 1:25
The diagnosis of early T-cell precursor (ETP) ALL
Bijal Shah • 17 Feb 2018
The evolving genomic landscape of ALL: molecular genetics, profiling and classification 11:57
The evolving genomic landscape of ALL: molecular genetics, profiling and classification
Anjali Advani et al. • 17 Feb 2018
Recent subtypes of ALL: Ph-like ALL and ETP ALL 10:31
Recent subtypes of ALL: Ph-like ALL and ETP ALL
Anjali Advani et al. • 17 Feb 2018
Phase III study shows tailored treatment improves response in T-lymphocytic leukemia 5:38
Phase III study shows tailored treatment improves response in T-lymphocytic leukemia
Brent Wood • 5 Dec 2014
Graft-versus-host disease (GvHD): Advances at EBMT 2016 3:12
Graft-versus-host disease (GvHD): Advances at EBMT 2016
Mohamad Mohty • 4 Apr 2016
Development and application of virus-specific T cells 2:58
Development and application of virus-specific T cells
Ann Leen • 4 Apr 2016
Bone marrow transplant consent: insight into patient motivations 3:15
Bone marrow transplant consent: insight into patient motivations
John Murray • 4 Apr 2016
The content of VJHemOnc is intended for healthcare professionals